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A B S T R A C T
Neurite loss is an early event in neurodegenerative diseases; therefore, the regeneration of the network
of neurites constitutes an interesting strategy of treatment for such disorders. Neurotrophic factors play
a critical role in neuronal regeneration, but their clinical use is limited by their inability to cross the blood
brain barrier. Oxidative and inﬂammatory events are implicated in neurodegeneration and antioxidant
compounds have been suggested as potential neuroprotectors. The protective potential of CAPE (caffeic
acid phenethyl ester) has been shown in different models of neurotoxicity (in vitro and in vivo) and it has
been associated with immune-modulatory, antioxidant and anti-inﬂammatory properties; however,
other mechanisms might be involved. The present study demonstrates that CAPE protects PC12 cells
from the cellular death induced by the dopaminergic neurotoxin MPP+ by increasing the network of
neurites. Results showed that CAPE induced the formation, elongation and ramiﬁcation of neurites in
PC12 cells non-stimulated with NGF (nerve growth factor) and inhibited the shortage of neurites induced
by the dopaminergic neurotoxin. These effects were associated with increased expression of neuron-
typical proteins responsible for axonal growth (GAP-43) and synaptogenesis (synaptophysin and
synapsin I). It is noteworthy that, unlike neurotrophins, CAPE would be able to cross the blood brain
barrier and exert its neurotrophic effects in the brain. This study corroborates the therapeutic potential
of CAPE in neurodegenerative diseases while proposes the involvement of neuroplasticity in the
mechanism of neuroprotection.
 2014 Elsevier Inc. All rights reserved.
Contents lists available at ScienceDirect
NeuroToxicology1. Introduction
There is a body of evidence of the neuroplasticity of the adult
brain. The formation of neurons in the mature brain due to the
proliferation and differentiation of adult neural stem cells has been
demonstrated and the concept of the irreversibility of the neuronal
loss is no longer a paradigm (Park and Lee, 2011; Zhao et al., 2008).
Neurotrophic protein factors such as NGF; BDNF; and GDNF play a
critical role in neuronal survival and regeneration (Gottlieb et al.,
2010). Alterations in the levels and activity of neurotrophic factors
or even in their receptors can lead to neuronal death; and have
been associated with neurodegenerative diseases. Based on these
ﬁndings new strategies for neuroprotection have emerged and* Corresponding author at: Department of Clinical Analyses, Toxicology and Food
Sciences, School of Pharmaceutical Sciences of Ribeira˜o Preto, University of Sa˜o
Paulo, Avenida do Cafe´ s/n, 14040-903 Ribeira˜o Preto, SP, Brazil.
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0161-813X/ 2014 Elsevier Inc. All rights reserved.the neurotrophic factors have been proposed as alternatives to
treat amyotrophic lateral sclerosis; as well as Parkinson’s;
Alzheimer’s and Huntington’s diseases (Levy et al., 2005; Wyman
et al., 1999; Zuccato and Cattaneo, 2009; Colombo et al., 2012;
Sullivan and Toulouse, 2011). Experimental studies in animal
models of Parkinson’s disease suggest that neurotrophins and
ligands of GDNF family protect against degeneration and;
moreover; promote regeneration of the nigrostriatal dopamine
system (Rangasamy et al., 2010). It has been demonstrated that the
nigrostriatal administration of GDNF protects dopamine neurons
against the neurotoxicity induced by MPTP (1-methyl-4-phenyl-
1;2;3;6-tetrahydropyridine) in primates (Kordower et al., 2000)
and 6-OHDA (6-hydroxydopamine) in rats (Fox et al., 2001).
Besides neurogenesis, neurite outgrowth is also important for
restoring the function in neurodegenerative processes; therefore,
compounds able to accelerate neurite extension might have
beneﬁcial effects in such disorders. Neurodegenerative diseases
could be managed by an approach that both stimulated and
accelerated the regeneration of the neuronal network (Gottlieb
et al., 2010; Sofroniew et al., 2001; Lad et al., 2003).
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to exert protective effect in different models of neurotoxicity
induced (i) in vitro by glutamate (Wei et al., 2008), 6-hydroxydo-
pamine (Noelker et al., 2005) and MPP+ (1-methyl-4-phenylpyr-
idinium), or even (ii) in vivo by MPTP (1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine) (Fontanilla et al., 2011). The neuroprotective
effect of CAPE has been mainly attributed to its immune-
modulatory, anti-inﬂammatory and antioxidant properties (Kasai
et al., 2011; Araujo et al., 2012; Natarajan et al., 1996; Noelker et al.,
2005). Additionally, it has been shown that artepillin C, a component
of propolis, stimulates neurite outgrowth in PC-12m3, a mutant cell
line irresponsive to NGF (Kasai et al., 2011; Kano et al., 2008).
However, despite the neuroprotective potential of CAPE, its effect on
neurite outgrowth has not been investigated yet. Therefore, in the
present study we evaluated the potential of CAPE to induce
neuritogenesis in PC-12 cells and investigated the involvement of
this mechanism in the protection against the cell death induced by
the dopaminergic neurotoxin MPP+. Additionally, the effects on the
expression of proteins associated with axonal growth (GAP-43) and
synaptogenesis (synapsin I and synaptophysin) were investigated.
2. Materials and methods
2.1. Chemicals
High purity reagents were used (analytical grade minimum).
Reagents were obtained from Sigma–Aldrich1, unless speciﬁed
differently. Cell culture media were purchased from Invitrogen
(Carlsbad, CA). Reagents for Western blot were purchased from
Bio-Rad1. Type I water (ultra-pure) was obtained in the puriﬁca-
tion system by reverse osmosis (Rios DI-3), followed by puriﬁca-
tion in Milli-Q Gradient system (Millipore, Bedford, USA). CAPE
was dissolved in DMSO (stock solution) and stored in freezer
(20 8C). Working solutions were prepared in DMEM without
phenol prior to assays.
2.2. Cell culture
PC-12 cells were obtained from the American Type Culture
Collection (ATCC) and cultured in Dulbecco’s Modiﬁed Eagle
Medium (DMEM, Gibco1), and supplemented with 5% heat-
inactivated fetal bovine serum (FBS), 10% heat-inactivated horse
serum and 1% antibiotic mixture (5 mg/mL penicillin, 5 mg/mL
streptomycin and 10 mg/mL neomycin). Cells were kept at 37 8C in
humidiﬁed atmosphere containing 5% CO2 and 95% air.
Medium was renewed every 3 days. Cells were split (2:20)
every 7–9 days. Conﬂuent cultures were washed with pre-warmed
Phosphate Buffered Saline (PBS), detached with trypsin/EDTA
solution (Gibco1), centrifuged, and subcultured. Cells were plated
in poly-lysine-coated, 12-well (neurites assay) or 96-well (cell
viability) plates at the appropriate density for each assay,
incubated for 24 h for better adhesion, and then treated as follows:
(a) untreated cells (control), (b) 100, 500 or 1000 mM MPP+
(Parkinson model), (c) 1, 5 or 10 mM CAPE, (d) 10 mM CAPE
followed by the addition of 100, 500 or 1000 mM MPP+
(cytotoxicity model). CAPE was added 24 h before the addition
of MPP+, and then cells were incubated again for 24 h.
2.3. Differentiation assays
PC-12 cells (2.0  105 cells/well) were plated in 12-well plates
and incubated for 24 h for better adhesion. After this period, the
medium was replaced by F-12K Nutrient Mixture Kaighn’s
Modiﬁcation (GIBCO1) supplemented with 1% horse serum, 1%
antibiotic mixture and NGF (100 ng/mL). Cells were treated with
MPP+ (100, 500 and 1000 mM) and CAPE (1, 5 or 10 mM) to evaluatethe protective effect of CAPE against the dopaminergic neurotoxin.
In the assays to evaluate the intrinsic effect of CAPE on cell
differentiation, NGF was only added in positive controls (NGF
group).
Morphometric analysis was performed on digital images of the
cells taken under inverted light microscopy (at 400 magniﬁca-
tion). Images from four ﬁelds per well were taken every 24 h of
incubation, from 24 h to 192 h. Neurites length, the number of
neurites/cell, maximum neurite length, branch points and the
percentage of differentiated cells were analyzed in the Image J
software (NIH image). Only those cells with at least one neurite
with a length equal to (or higher than) the cell body diameter were
considered to be differentiated (Das et al., 2004; Kim et al., 2014).
Experiments were repeated three times using cell cultures
prepared on different days. The experiments of each day were
performed in triplicates.
2.4. Cell viability
Cell viability and mitochondrial function were measured using
the MTT assay, which is based on the conversion of MTT to
formazan crystals by mitochondrial dehydrogenases (Hansen et al.,
1989). Only viable mitochondria containing NADPH dehydroge-
nase activity are able to cleave MTT and produce formazan, which
is monitored at 570 nm (Huet et al., 1992; Zhao et al., 2005). Cells
were treated as earlier described, added with 20 mL of 5 mg/mL
MTT and incubated for 3 h. The supernatant was withdrawn and
20 mL of DMSO were added to dissolve the formazan crystals.
Absorbance was read at 570 nm on a microplate reader (Multiskan
FC, Thermo Scientiﬁc). Cell viability was expressed as a percentage
of the control.
2.5. Preparation of cell lysate for Western blot analyses:
After incubation (72 h, 37 8C) with MPP+, CAPE or NGF, cells
(2  105) were rinsed with cold PBS and mixed with 200 mL Tris-
Triton lysis buffer (10 mM Tris, pH 7.4, 100 mM NaCl, 1 mM
EDTA, 1 mM EGTA, Triton X-100 1%, 10% glycerol, 0.1% SDS, 0.5%
deoxycholate, 1:200 protease inhibitor cocktail, and 1% phos-
phatase inhibitor). The lyse procedure was performed with
tubes placed on ice to reduce the activity of proteases. Cells
were then harvested and transferred to centrifuge microtubes
and incubated (300 rpm, 30 min, 4 8C). After centrifugation
(12,000 rpm for 20 min at 4 8C), the precipitates were discarded,
and cell lysates (supernatants) were stored in a freezer (80 8C)
until assayed. A 10 mL aliquot of each cell lysate was assayed
for protein determination by the Bradford method described
below.
2.6. Determination of protein in cell lysate (Bradford)
The reactive color Protein Assay Dye Reagent Concentrate (Bio-
Rad) was used according to the protocol suggested by the
manufacturer. The lysates were diluted with water (1:5) and a
calibration curve of BSA (40, 100, 200 and 400 mg/mL) was
prepared. The color reagent was diluted with water (1:5). The color
reaction was performed in 96 well plates by adding 10 mL of
diluted sample or standard and 200 mL of diluted dye reagent. The
absorbance (595 nm) was determined in a microplate reader after
5 min agitation. Due to the known interference of some
components of the lysis buffer in the reaction of Bradford, controls
containing 10 mL of diluted lysis buffer were carried out and
the average absorbance of them was subtracted from the
absorbance values of samples. Concentrations of protein in
samples were calculated based on the calibration curve response
and multiplied by the dilution factor (5).
Fig. 1. (A) Effect of different concentrations of CAPE (1, 5 and 10 mM) on the
differentiation of PC12 cells after 24 h of incubation and (B) effect of long-term (24–
192 h) incubation with CAPE (10 mM) on differentiation of PC12 cells.
Differentiation medium: F-12K Nutrient Mixture Kaighn’s Modiﬁcation
(GIBCO1) supplemented with 1% horse serum and 1% antibiotic mixture. NGF
(100 ng/mL) was only added in the NGF group, as described in Section 2. Data are
expressed as mean  SEM and are representative of three independent experiments;
each experiment was performed in triplicates. *Signiﬁcantly different from the control
(p < 0.05); #signiﬁcantly higher than NGF-stimulated cells (p < 0.05).
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2.7.1. SDS–PAGE:
Samples were diluted in equal volume of Laemli sample buffer
(2) and heated for 10 min at 95 8C. Aliquots of 35 mL containing
10 mg total protein were applied to 10% polyacrylamide gel
(10 wells) and separated by electrophoresis (1 h, 160 V) in
electrophoresis tank containing 1 L of Tris/glycine buffer (Bio-Rad).
2.7.2. Transfer:
Proteins were transferred to nitrocellulose membranes (1 h,
0.37 A) in electrophoresis tank (Bio-Rad) containing 1 L of Tris/
Glycine/SDS buffer (Bio-Rad).
2.7.3. Immune reaction:
The membranes were blocked (30 min, RT, 300 rpm) with 5%
BSA in Tween 20/TBS buffer (TBST), and incubated (overnight, 4 8C,
300 rpm) with primary antibody: anti-synaptophysin (1:400), or
anti-GAP-43 (1:1250), or anti-synapsin I (1:1000); washed with
TTBS and incubated (1 h, RT, 300 rpm) with a secondary antibody
conjugated to horseradish peroxidase (anti-mouse or anti-rabbit
IgG-HRP, 1:20,000). The membranes were washed with TTBS and
TBS and treated with 3 mL of chemiluminescence enhancer
detection reagents (1:1). Bands were detected by chemilumines-
cence and images were captured by using ChemiDoc system (Bio-
Rad Laboratories, Inc., Hercules, CA, USA). Quantitation of the
digitalized images was performed based on the optical densitom-
etry (OD) of the bands by using the open source software Image J
(NIH, USA). Subsequently membranes were stripped (2% SDS,
62.5 mM Tris pH 6.8 and 100 mM mercaptoethanol) and reprobed
for b-actin protein (loading control). Immunoreaction was carried
out by using a monoclonal anti-b-Actin antibody (1:3000) and
anti-mouse IgG-HRP (1:20,000). The procedures for chemilumi-
nescent detection were repeated. After quantiﬁcation of b-actin
bands, OD values of synaptophysin, synapsin and GAP-43 were
divided by the OD values of b-actin for normalization of the results
(L’episcopo et al., 2011). All antibodies were purchased from
Sigma–Aldrich1 (St Louis, MO, USA) and the dilutions used were
within the range recommended by the manufacturer.
2.8. Statistical analysis
All data were expressed as mean  SEM. Statistical analysis was
carried out by using Two-way ANOVA and Multiple t-test with Holm–
Sidak method (GraphPad Software, San Diego, California, USA). Values
of p < 0.05 were considered signiﬁcant.
3. Results
3.1. Effects of different concentrations of CAPE on the differentiation of
PC12 cells
The three evaluated concentrations of CAPE signiﬁcantly
induced PC-12 cells differentiation after 24 h-incubation as
compared to control. The induction was dependent on the
concentration as showed by the percentage of differentiated cells
exposed to 1 mM, 6.47  0.42%; 5 mM, 11.03  0.40%; and 10 mM,
22.81  1.27%. All of them were signiﬁcantly different from the
negative control (3.40  0.29%). Moreover, the number of differenti-
ated cells in the presence of 10 mM CAPE was signiﬁcantly higher
than in the positive control, in which differentiation was stimulated
with NGF 100 ng/mL (17.89  0.49%). Results are presented in
Fig. 1A. Based on these ﬁndings, this concentration of CAPE
(10 mM) was used to evaluate all the other parameters.
The analysis of cellular differentiation during 192 h of incuba-
tion showed that the percentage of differentiated cells amongthose exposed to 10 mM of CAPE (from 20.83 to 66.61%) was
approximately 2-fold higher than the number of differentiated
cells induced by 100 ng/mL of NGF (from 10.70 to 42.50%). The
differentiation induced by CAPE increased up to 96 h and then a
plateau was observed from 96 h (62.5  4.79%) to 192 h
(66.61  5.63%). Differently, in the NGF group, differentiation
increased during the whole period of incubation, but was always
lower than in the CAPE group. The representative traces are presented
in Fig. 1B.
The photomicrographs in Fig. 2A show the morphological
changes of PC-12 cells treated with NGF or 10 mM CAPE after 24 h,
48 h and 72 h of incubation. In their native state, PC-12 cells are
polygonal shaped and very few cells possess neurites, while those
exposed to NGF (positive control) or CAPE, form neurite exten-
sions. Besides cells differentiation, longer neurites can be observed
in the photomicrograph of cells incubated with CAPE (10 mM) for
72 h.
The percentage of differentiated PC-12 cells was signiﬁcantly
higher in the CAPE group (24 h, 20.83  2.85%; 48 h, 35.33  5.52%
and 72 h, 36.93  2.21%) as compared to the negative controls (24 h,
3.40  0.29%; 48 h, 7.6  0.75% and 72 h, 11.41  1.25%), or even to
the positive controls (24 h, 10.70  0.72%; 48 h, 14.45  1.04% and
72 h, 18.33  1.54%), as represented by the bar graphs at Fig. 2B–D,
respectively.
3.2. Effect of CAPE on neuritogenesis
CAPE induced the formation of neurites (Fig. 3A), the elongation
of neurites (Fig. 3B and C) and neurites branching (Fig. 3D) in PC12
cells. Monitoring from 24 h to 192 h showed an increase in the
number of neurites in the cells exposed to CAPE as compared to
Fig. 2. (A) Photomicrographs showing the morphological changes of PC12 cells exposed to 10 mM CAPE or stimulated with NGF (100 ng/mL) after 72 h-incubation. (B) (C) and
(D) Bar graphs showing the statistical signiﬁcance of PC12 cells differentiation induced by CAPE and NGF after incubation for 24 h (B), 48 h (C) and 72 h (D). Data from four
ﬁelds in each well were pooled and used to calculate the percentage in relation to the total number of cells in the ﬁelds. The controls consisted of non-exposed cells incubated
for 24, 48 or 72 h. Differentiation medium: F-12K Nutrient Mixture Kaighn’s Modiﬁcation (GIBCO1) supplemented with 1% horse serum and 1% antibiotic mixture. NGF
(100 ng/mL) was only added in the NGF group, as described in Section 2. Data are expressed as mean  SEM and are representative of three independent experiments; each
experiment was performed in triplicates. *Signiﬁcantly different from the control (p < 0.05); # Signiﬁcantly different from NGF-stimulated cells (p < 0.05).
Fig. 3. Effects of CAPE (10 mM) on neurite growth after long-term (24–192 h) incubation. (A) Number of neurites/cell, (B) neurite elongation: neurite length/cell, (C) neurite
elongation: maximum neurite length and (D) branch points/cell. Differentiation medium: F-12K Nutrient Mixture Kaighn’s Modiﬁcation (GIBCO1) supplemented with 1%
horse serum and 1% antibiotic mixture. NGF (100 ng/mL) was only added in the NGF group, as described in Section 2. Data are expressed as mean  SEM and are representative
of three independent experiments; each experiment was performed in triplicates. *Signiﬁcantly different from the control (p < 0.05); #Signiﬁcantly higher than NGF-stimulated
cells (p < 0.05).
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number of neurites/cell in CAPE and NGF groups was similar up to
72 h, but after this period CAPE was more effective than NGF as
demonstrated by the traces in Fig. 3A. CAPE also induced longer
neurites than NGF. CAPE-induced elongation of neurites was
observed up to 124 h and the longest neurite was observed after
144 h of incubation (Fig. 3B and C). The number of branch points
was not increased by NGF as demonstrated by the overlaid traces of
NGF and negative control; while CAPE was able to increase the
number of branch points from 24 h to 192 h (Fig. 3D).
3.3. CAPE minimized the inhibition of cellular differentiation induced
by MPP+
CAPE (10 mM) was able to signiﬁcantly minimize the
inhibition of cells differentiation induced by different concentra-
tions of the neurotoxin MPP+ (CAPE + 100 mM MPP+, 12.90  1.30;Fig. 4. Effects of MPP+ and CAPE on cellular differentiation. (A) Bar graph showing
the statistical signiﬁcance of the effects of different concentrations of MPP+ (100,
500 and 1000 mM) on PC12 cells’ differentiation; (B) bar graph showing the
statistical signiﬁcance of the protective effect of 10 mM CAPE against different
concentrations of MPP+ (100, 500 and 1000 mM). Differentiation medium: F-12K
Nutrient Mixture Kaighn’s Modiﬁcation (GIBCO1) supplemented with 1% horse
serum, 1% antibiotic mixture and NGF (100 ng/mL) as described in Section 2. Data
are expressed as mean  SEM and are representative of three independent
experiments; each experiment was performed in triplicates. *Signiﬁcantly different
from the respective control (p < 0.05).CAPE + 500 mM MPP+, 7.87  0.31 and CAPE + 1000 mM MPP+,
1.38  1.38) as compared to MPP+ alone (6.28  0.22%; 2.22 
0.13% and 0.008  0.001%, respectively) (Fig. 4).
3.4. Protective effect of CAPE against MPP+-induced cell death
As shown in Fig. 5A, the viability of cells incubated with 100 mM
(96.63  3.69%) or 500 mM (88.59  3.74%) was not signiﬁcantly
different from that of the control. Only 1000 mM MPP+ was able to
signiﬁcantly reduce cells viability (56.42  3.57%) and therefore, the
protective effect of CAPE against cell death was evaluated in the
presence of 1000 mM MPP+.
Among the three concentrations of CAPE tested (1, 5 and
10 mM), only 10 mM CAPE (88.68  7.19% of control) signiﬁcantly
prevented MPP+-induced cell death as compared to MPP+
(56.42  3.58% of control). The lower concentrations of CAPE were
not able to signiﬁcantly reduce the cell death in the presence of
1000 mM MPP+. Cell viability was 54.60  2.35% in the presence of
MPP+ + 1 mM CAPE, and 65.93  4.34 in the presence of MPP+ + 5 mM
CAPE. Although a tendency to protect is observed in the latest, the
difference in relation to MPP+ was not signiﬁcant (Fig. 5B).Fig. 5. Effects of MPP+ and CAPE on cellular viability. (A) Effects of different
concentrations of MPP+ (100, 500 and 1000 mM); (B) protective effect of CAPE (1, 5
and 10 mM) against the cellular death induced by 1000 mM MPP+. Analytical and
experimental conditions were described in Section 2. Data are expressed as
mean  SEM and are representative of three independent experiments; each
experiment was performed in triplicates. *Signiﬁcantly different from control
(p < 0.05). #Signiﬁcantly different from MPP+ (p < 0.05).
Fig. 7. Expression of Synaptophysin in PC12 cells. Cells were treated or not (control)
with NGF 100 ng/mL or CAPE 10 mM and lysates were assayed by SDS–PAGE and
Immunoblotting. (A) Representative immunoblotting of synaptophysin and b-
actin. (B) Representative graph of Optical Density (OD) of synaptophysin
normalized with b-actin. Analytical and experimental conditions were described
in Section 2. Data are expressed as mean  SEM and are representative of three
independent experiments; each experiment was performed in triplicates.
*Signiﬁcantly different from control (p < 0.05).
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CAPE alone (without NGF) signiﬁcantly increased the expres-
sion of GAP-43 (4.02  0.34), synaptophysin (5.53  1.03) and
synapsin (3.2  0.73) as compared to non-treated cells (control,
1.26  0.076; 0.99  0.03 and 0.75  0.19, respectively). Cells treated
with only NGF 100 ng/mL were used as positive controls. NGF
signiﬁcantly increased the expression of GAP-43 (3.41  0.53),
synaptophysin (3.50  0.27) and synapsin (2.10  0.26) as compared
to controls (Fig. 6, Fig. 7 and Fig. 8, respectively).
4. Discussion
In a previous study we demonstrated the protective effect of
CAPE in rats treated with 6-hidroxydopamine (6-OHDA) and
associated the protection with ROS scavenging, metals chelation
and inhibition of the Mitochondrial Permeability Transition (MPT)
(Silva Barros et al., 2013). In the present study we hypothesized
that CAPE would also have a beneﬁcial effect on neuroplasticity
and showed that CAPE induces neuritogenesis in non-stimulated
PC-12 cells (without the addiction of NGF). Our results suggest that
the neuritogenic effect of CAPE is not synergistic, i.e., does not
depend on the combination with NGF. In fact, at a concentration of
10 mM, CAPE was even more effective in stimulating the
differentiation of PC12 cells than 100 ng/mL of NGF, which is a
concentration proved efﬁcacious in several studies (Das et al.,
2004; Gottlieb et al., 2010; Koch et al., 2008). The differentiation of
PC12 cells induced by CAPE in our study was time and
concentration-dependent. Besides increasing the percentage of
differentiated cells, CAPE also increased the number of neurites per
cell and promoted neurites elongation. Cells exposed to CAPE
(10 mM) presented more and longer neurites than those stimulat-
ed with NGF (100 ng/mL) .
CAPE also induced neurites branching, and this effect was
intensiﬁed after 144 h of incubation. Neurite branching plays aFig. 6. Expression of GAP-43 in PC12 cells. Cells were treated or not (control) with
NGF 100 ng/mL or CAPE 10 mM and lysates were assayed by SDS–PAGE and
immunoblotting. (A) Representative immunoblotting of GAP-43 and b-actin. (B)
Representative graph of Optical Density (OD) of GAP-43 normalized with b-actin.
Analytical and experimental conditions were described in Section 2. Data are
expressed as mean  SEM and are representative of three independent experiments;
each experiment was performed in triplicates. *Signiﬁcantly different from control
(p < 0.05).critical role in the integration of appropriate sets of neurons and,
therefore, it is essential for the neuronal development and
regeneration (Higuchi et al., 2003; Lalli and Hall, 2005).
Neurotrophins and several other guidance cues have been
associated with neurite branching (Dent et al., 2004; Acebes and
Ferrus, 2000); however, in our model, NGF did not induce neurite
branching. This ﬁnding is in line with a previous report which
suggests that the PI3K-Akt pathway inhibits neurite branching in
NGF-treated PC12 cells (Higuchi et al., 2003). Furthermore, there is
evidence that the branching effect depends on the types of neurites
(dendrite or axon, distal or proximal), and on the speciﬁcity
between the neurotrophin and the cell-type (Acebes and Ferrus,
2000; Higuchi et al., 2003). This speciﬁcity might also explain why
NGF did not induce neurite branching in our cellular model.
The beneﬁcial effect of CAPE on neuroplasticity was conﬁrmed
by the increased expression of neuron-typical proteins involved
in axonal growth (GAP-43) and synaptogenesis (synaptophysin
and synapsin I). These data suggest that not only CAPE induces
neurite formation and elongation via up-regulation of GAP-43,
but it also induces the formation of synaptic vesicles via up-
regulation of synaptophysin and synapsin I. These proteins have
been associated with differentiation and neurite outgrowth in
PC12 cells (Das et al., 2004) and up-regulation of them have been
found in PC12 cells stimulated with NGF (Romano et al., 1987;
Van Hooff et al., 1986). Therefore, our study is in line with
previous studies which demonstrated (i) that CAPE protects nigral
dopaminergic neurons via induction of brain-derived neuro-
trophic factor (BDNF) (Kurauchi et al., 2012) and (ii) induces the
expression of NGF and p75 neurotrophin receptor (p75NTR) in C6
glioma cells (Lin et al., 2010b). NGF binding to p75NTR has been
associated with both neuronal survival and death, and the
balance of these opposing effects is important in the develop-
ment, maintenance and regeneration of the nervous system
(Yamashita et al., 2005).
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ramiﬁcation of neurites in PC12 cells, CAPE was also able to
minimize the cellular death and the neurite loss induced by the
dopaminergic neurotoxin MPP+, which is the active metabolite of
MPTP, a neurotoxin used in animal models of Parkinson’s disease.
CAPE improved the cellular morphology, induced neurite exten-
sion and increased the cellular viability of PC12 cells exposed to
MPP+. Increased neuronal viability in the presence of 10 mM CAPE
had also been observed in rat rostral mesencephalic neurons
(RMN) and cerebellar granule neurons (CGN) treated with 6-
hidroxydopamine (6-OHDA), another dopaminergic neurotoxin
(Noelker et al., 2005).
In the present study, MPP+ reduced the cellular differentiation
in a concentration-dependent manner. Interestingly, at 1000 mM,
MPP+ totally blocked the differentiation of PC12 cells, but reduced
the cell viability to approximately 56%. Accordingly, it has been
demonstrated that MPP+ causes degeneration of neurites and
autophagy in dissociated dopamine neurons cultures, before the
occurrence of cell body loss (Kim-Han et al., 2011). All together,
these ﬁndings suggest that inhibition of neurites outgrowth might
be an early event in neurodegeneration and that the induction of
neuritogenesis might be an approach of treatment.
Several mechanisms of neuroprotection have been associated
with CAPE, and most of them are related to its antioxidant and free-
radical scavenging ability. This is the ﬁrst study to demonstrate
that the neuroprotective mechanism of CAPE might also involve
the induction of neuritogenesis. It is known that the levels of
neurotrophic factors or their receptors are altered in neurodegen-
erative diseases and therefore, neurotrophic factors have been
suggested as potential candidates of treatment for such diseases
(Levy et al., 2005; Lanni et al., 2010). However, neurotrophic
factors, including NGF, are not able to cross the blood brain barrierFig. 8. Expression of Synapsin I in PC12 cells. Cells were treated or not (control) with
NGF 100 ng/mL or CAPE 10 mM and lysates were assayed by SDS–PAGE and
immunoblotting. (A) Representative immunoblotting of synapsin I and b-actin. (B)
Representative graph of Optical Density (OD) of synapsin normalized with b-actin.
Analytical and experimental conditions were described in Section 2. Data are
expressed as mean  SEM and are representative of three independent experiments;
each experiment was performed in triplicates. *Signiﬁcantly different from control
(p < 0.05).(Lin et al., 2010a). In this context, CAPE represents an interesting
alternative, because it is able to cross the blood brain barrier (Khan
et al., 2007). In fact, we have recently demonstrated that the
intraperitoneal administration of CAPE protects against the
dopaminergic neuronal loss in rats treated with stereotaxic
injections of 6-hydroxydopamine, a model of early-to-mid stage
Parkinson’s disease (Silva Barros et al., 2013). Altogether the
ﬁndings of both studies suggest that CAPE might be used in
therapeutic strategies against neurodegeneration.
5. Conclusion
CAPE induces formation, elongation and ramiﬁcation of
neurites in PC12 cells and these effects are associated with the
increased expression of GAP-43, synapsin and synaptophysin.
Additionally, CAPE minimizes both the inhibition of neuritogenesis
and the cell death induced by MPP+. The inhibition of neuritogen-
esis precedes the cell loss induced by MPP+ in PC12 cells and this
ﬁnding supports the key role of neuritogenesis in the management
of neurodegenerative processes. CAPE is a natural, non-toxic,
antioxidant and anti-inﬂammatory compound, which can cross the
BBB, and according to our ﬁndings, induces neuritogenesis and
synaptogenesis. Altogether, these features make CAPE a potential
candidate for protection against neurodegeneration.
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